newsfilter
← Latest News
ACCESS Newswire·

IGC Pharma Announces Preclinical Data Demonstrating TGR-63's Dual Action on Alzheimer's Pathology

POTOMAC, MD / ACCESS Newswire / September 24, 2025 / IGC Pharma, Inc. today announced preclinical findings on TGR-63, the Company's investigational small-molecule candidate for Alzheimer's disease. The data